A Phase 2, Dose Escalation, Schedule Comparison Study to Evaluate the Safety, Pharmacokinetics, and Viral Kinetics of ABX464 in Untreated Patients With HIV Infection in Mauritius
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Obefazimod (Primary)
- Indications HIV infections; HIV-1 infections; HIV-2 infections
- Focus Adverse reactions
- Sponsors Abivax
- 27 May 2016 Status changed from recruiting to completed.
- 02 Feb 2015 According to an Abivax media release, the first HIV positive patient was dosed on 2 Feb 2015.
- 02 Feb 2015 Status changed from planning to recruiting, according to an Abivax media release.